Anthropic IPO Discloses Plans for Life Sciences Growth

Anthropic’s Form S-1 Registration Statement did not reveal what research areas it is pursuing through the molecular biology lab it disclosed last month, and what if any new therapies it is seeking to discover and develop. But the IPO filing said that Anthropic is creating AI agents based on its…

aibusinessscience

Sources